Clinical trial
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
NCT01838512 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
- Lead sponsor
- Bristol-Myers Squibb
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- June 13, 2012
- Completion date
- March 31, 2030
- Enrollment
- 2,555 (estimated)
- Sites
- 130
Conditions
As the registry lists them; a condition with its own page is linked.